Adriana C. Gamboa, M.D., MSc

Department of Surgical Oncology, Division of Surgery

Present Title & Affiliation

Primary Appointment

Assistant Professor, Surgical Oncology, Section of Hepatobiliary Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Education & Training

Degree-Granting Education

2020	Emory University Laney Graduate School, Atlanta, GA, US, Clinical Research, Master of Science
2016	Baylor College of Medicine, Houston, Texas, US, Medical Doctorate
2012	Rice University, Houston, Texas, US, Bioengineering, Bachelor of Science

Postgraduate Training

2023-2025	Fellow, Complex General Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2020-2023	Resident, General Surgery, Emory University School of Medicine, Atlanta, GA
2018-2020	Katz Foundation Research Fellow, Winship Cancer Institute at Emory University School of Medicine, Atlanta, Georgia
2017-2018	Resident, General Surgery, Emory University School of Medicine, Atlanta, Georgia
2016-2017	Intern, General Surgery, Emory University School of Medicine, Atlanta, Georgia

Honors & Awards

2020 - Present	Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology
2019 - Present	Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology
2018 - 2020	Katz Foundation Surgical Oncology Fellowship
2018 - 2019	NIH/NCATS Georgia Clinical and Translational Science Alliance TL1 Predoctoral Research Training Award (TL1TR002382, PI: Blumberg)
2015 - Present	Gold Humanism Honor Society
2015 - Present	Texas Medical Association Scholarship

Professional Memberships

American Society of Colon & Rectal Surgeons

2019 - Present

Society of Surgical Oncology

2018 - Present

American Society of Clinical Oncology

2018 - Present

Americas Hepato-Pancreato-Biliary Association

2018 - Present

Gold Humanism Honor Society

2016 - Present

American College of Surgeons

2016 - Present

Selected Presentations & Talks

National Presentations

2026. Management of Localized Cholangiocarcinoma. Invited. Cholangiocarcinoma Foundation. Salt Lake Cit, Utah, US.
2026. Liver Directed Therapies for Colorectal Liver Metastases. Invited. 4th Annual Young Onset Colorectal Cancer Patient Conference. Houston, Texas, US.
2025. Clinical and Molecular Features of Young-Onset Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis”. Invited. San Diego, CA, US.
2025. Mapping multimorbidity trajectories for pancreas cancer for real world data”. Poster. Tampa, FL, US.
2025. Characterizing the molecular profile and long-term outcomes of patients with young-onset pancreas adenocarcinoma. Invited. La Jolla, CA, US.
2021. Outcomes Following a Rectal and/or Simultaneous Versus Liver-First Approach for Synchronous Rectal Liver Metastasis: An Analysis of the U.S. Rectal Cancer Consortium - [Presented by Co-Investigator]. Invited, US.
2021. Short-Course Radiation with Consolidation Chemotherapy Does Not Increase Operative Morbidity Compared to Long-Course Chemoradiation – A Retrospective Study of the U.S. Rectal Cancer Consortium - [Presented by Co-Investigator]. Invited, US.
2021. Is there a Role for Adjuvant Chemotherapy in Pathologic Node-Negative, Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy? - [Presented by Co-Investigator]. Invited, US.
2021. Impact of Persistent Retroperitoneal and Lateral Pelvic Lymph Nodes After Neoadjuvant Therapy on Long-term Outcomes: An Analysis of the United States Rectal Cancer Consortium - [Presented by Co-Investigator]. Invited, US.
2020. Should Signet-Ring Cell Histology Alter the Treatment Approach for Gastric Cancer? A National Cancer Database Study - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2020. Time from Diagnosis to Treatment of Pancreatic Cancer: An Emergency of the Mind?”. Invited. Miami, FL, US.
2020. The Evolving Landscape of Hepatocellular Carcinoma: A United States Safety Net Collaborative Analysis of Etiology of Cirrhosis - [Presented by Co-Investigator]. Invited. New Orleans, LA, US.
2020. A Novel Preoperative Risk Score to Optimize Patient Selection for Performing Concomitant Liver Resection with Cytoreductive Surgery/ HIPEC - [Presented by Co-Investigator]. Invited. Orlando, FL, US.
2020. A Novel Preoperative Risk Score to Optimize Patient Selection for Performing Concomitant Liver Resection with Cytoreductive Surgery/ HIPEC - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2020. Impact of Hepatitis C Treatment on Long-term Outcomes for Patients with Hepatocellular Carcinoma: A US Safety-Net Collaborative Study - [Presented by Co-Investigator]. Invited. Miami, FL, US.
2020. Outcome Differences Between Safety Net and Academic Institutions for Hepatocellular Carcinoma Driven by Stage at Diagnosis Rather Than Racial/Ethnic or Socioeconomic Disparities: An Analysis from the United States Safety Net Collaborative - [Presented by Co-Investigator]. Invited. Miami, FL, US.
2020. Adjuvant Therapy for Patients Achieving pCR Following Neoadjuvant Therapy and Radical Excision May Be Overkill - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2020. Perioperative Blood Transfusions are Associated with Worse Disease-Free Survival and Overall Survival After Curative Rectal Cancer Resection: A Propensity Weighted Analysis - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2020. Impact of time to initiation of treatment for rectal cancer: do the guidelines matter? - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2020. Implications of Postoperative Complications on Survival after Cytoreductive Surgery and HIPEC: A Multi- Institutional Analysis of the US HIPEC Collaborative”. Poster. San Francisco, CA, US.
2020. “Should Adenosquamous Esophageal Carcinoma be Treated like Adenocarcinoma or Squamous Cell Carcinoma?”. Poster. San Francisco, CA, US.
2020. Impact of Postoperative Complications on Oncologic Outcomes after Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium. Invited. San Francisco, CA, US.
2020. Implications of Postoperative Complications on Survival after Cytoreductive Surgery and HIPEC: A Multi- Institutional Analysis of the US HIPEC Collaborative. Poster. Orlando, FL, US.
2020. Should Adenosquamous Esophageal Carcinoma be Treated like Adenocarcinoma or Squamous Cell Carcinoma?. Poster. Boston, MA, US.
2020. Impact of Postoperative Complications on Oncologic Outcomes after Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium. Poster. Boston, MA, US.
2020. Implications of Postoperative Complications on Survival after Cytoreductive Surgery and HIPEC: A Multi- Institutional Analysis of the US HIPEC Collaborative. Poster. Boston, MA, US.
2020. Revisiting the Value of Drains after Low Anterior Resection for Rectal Cancer: An Analysis of 996 Patients - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2020. A US Rectal Cancer Consortium Study of Inferior Mesenteric Artery versus Superior Rectal Artery Ligation: How High Do We Need to Go? - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2020. Should Signet-Ring Cell Histology Alter the Treatment Approach for Gastric Cancer? A National Cancer Database Study - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2020. The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After CRS and HIPEC - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2020. The Evolving Landscape of Hepatocellular Carcinoma: A United States Safety Net Collaboration Analysis of Etiology of Cirrhosis - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2020. The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After CRS and HIPEC - [Presented by Co-Investigator]. Poster. Orlando, FL, US.
2020. Revisiting the Value of Drains after Low Anterior Resection for Rectal Cancer: An Analysis of 996 Patients - [Presented by Co-Investigator]. Poster. Boston, MA, US.
2020. A US Rectal Cancer Consortium Study of Inferior Mesenteric Artery versus Superior Rectal Artery Ligation: How High Do We Need to Go? - [Presented by Co-Investigator]. Poster. Boston, MA, US.
2020. Evaluating synthetic data quality: Gaussian and CT-GAN models in replicating clinical outcomes in pancreas cancer research. Poster. Tampa, FL, US.
2020. A Novel Preoperative Risk Score to Guide Patient Selection for Resection of Sarcoma Lung Metastases: An Analysis from the U.S. Sarcoma Collaborative - [Presented by Co-Investigator]. Invited. Boston, MA, US.
2019. Differences in Outcome for Patients with Cholangiocarcinoma: Racial/Ethnic Disparity or Socioeconomic Factors? - [Presented by Co-Investigator]. Poster. San Francisco, CA, US.
2019. Differences in Outcomes for Patients with Cholangiocarcinoma: Racial/Ethnic Disparity or Socioeconomic Factors? - [Presented by Co-Investigator]. Poster. San Diego, CA, US.
2019. Interaction of Race and Pathology for Neuroendocrine Tumors: Epidemiology, Natural History, or Racial Disparity? - [Presented by Co-Investigator]. Poster. San Diego, CA, US.
2019. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: CT Scan or Chest X-ray? - [Presented by PI]. Poster. Tokyo, JP.
2019. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: CT Scan or Chest X-ray?. Invited. San Diego, CA, US.
2019. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: CT Scan or Chest X-ray?. Invited. Atlanta, GA, US.
2019. The Hand-Assist Laparoscopic Technique for Distal Pancreatectomy. Invited. Miami, FL, US.
2019. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis from the US HIPEC Collaborative - [Presented by Co-Investigator]. Invited. Phoenix, AZ, US.
2019. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A Twelve Institution Study from the US HIPEC Collaborative - [Presented by Co-Investigator]. Invited. Phoenix, AZ, US.
2019. Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi- Institutional Analysis of the US HIPEC Collaborative”. Invited. Phoenix, AZ, US.
2019. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. - [Presented by PI]. Invited. Dallas, TX, US.
2019. Race, Ethnicity, and Socioeconomic Factors in Cholangiocarcinoma: What is Driving Disparities in Receipt of Treatment?. Invited. Miami, FL, US.
2019. The Path to Whipple Reconstruction: Trans-Mesocolon Or Through Ligament of Treitz?. Invited. San Diego, CA, US.
2019. Duodenal Neuroendocrine Tumors: Somewhere Between the Pancreas and Small Bowel. Poster. San Francisco, CA, US.
2019. Duodenal Neuroendocrine Tumors: Somewhere Between the Pancreas and Small Bowel. Poster. San Diego, CA, US.
2019. Duodenal Neuroendocrine Tumors: Somewhere Between the Pancreas and Small Bowel. Poster. Washington, DC, US.
2019. A Novel Preoperative Risk Score to Predict Lymph Node Positivity for Rectal Neuroendocrine Tumors: An NCDB Analysis to Guide Operative Technique. Poster. Cleveland, OH, US.
2014. The Incidence and Risk Factors for Graft Infection of Chronically Occluded Prosthetic Grafts After Major Lower Extremity Amputation. Poster. Boston, MA, US.
2014. The Incidence and Risk Factors for Developing Lower Extremity Deep Vein Thrombosis after Major Amputation. Invited. New Haven, CT, US.
2010. Ex vivo Assessment of Functional Myocardial Mechanics. Poster. Houston, TX, US.
2009. Tissue Engineering of a Cardiac Muscle Construct on a Matrigel Scaffold. Poster. Houston, TX, US.

Less

Grant & Contract Support

Date:	2018 - 2020
Title:	Georgia Clinical and Translational Science Alliance NSRA (TL1) Training - Blumberg, Henry M. (PI)
Funding Source:	NIH/NCATS
Role:	Key
ID:	TL1TR002382

Selected Publications

Peer-Reviewed Articles

Tomita, K, Kim, M, Prakash, L, Gamboa, AC, Maxwell, JE, Snyder, RA, Tzeng, CD, Katz, MH, Ikoma, N. Phase-specific operative times in robotic distal pancreatectomy. HPB 28(6):826-833, 2026. e-Pub 2026. PMID: 41864834.
Ito, K, Jain, AJ, Newhook, TE, Tran Cao, HS, Tzeng, CD, Gamboa, AC, Vauthey, JN, Chun, YS. Total neoadjuvant therapy for rectal cancer. Surgery (United States) 194, 2026. e-Pub 2026. PMID: 41926846.
Gamboa, AC, Lewis, KA, Prakash, L, Li, Z, Qiao, W, Zhao, D, Hurd, MW, Yousef, M, Ikoma, N, Kim, M, Lee, JE, Maxwell, JE, Tzeng, CD, Katz, MH, Snyder, RA. Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. JCO Precision Oncology 10, 2026. e-Pub 2026. PMID: 41538760.
Wang, L, Li, R, Wen, A, Lu, Q, Wang, J, Ruan, X, Gamboa, AC, Malik, N, Roland, CL, Katz, MH, Lyu, H, Liu, H. Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient records. Journal of Biomedical Informatics 171, 2025. e-Pub 2025. PMID: 41120049.
Mavani PT, Ajay PS, Wagner HB, Meyer BI, Shah M, Sok CP, Gamboa AC, Goyal S, Switchenko JM, Maithel SK, Kooby DA, Shah MM. Defining the reliability of bladder scan in patients with obesity with postoperative urinary retention. Surgery 185:109547, 2025. e-Pub 2025. PMID: 40633286.
Goel CR, Gozza CM, Gamboa AC, Warren EK, Regenbogen SE, Hendren S, Holder-Murray J, Kalady M, Ejaz A, Hawkins AT, Silviera ML, K Maithel S, Balch GC, Rosen SA. Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis. Am Surg:31348251371207, 2025. e-Pub 2025. PMID: 40875479.
Ali D, Syed M, Gamboa AC, Hawkins AT, Regenbogen SE, Holder-Murray J, Wise P, Kalady MF, Balch GC, Khan A. Risk Factors for Delayed (>30 Days) Readmission Following Rectal Cancer Surgery. J Surg Res 306:397-406, 2025. e-Pub 2025. PMID: 39854802.
Barcellos da Cunha I, da Rosa GM, Gamboa AC, Volpi GB, Bones UA, Flach KA, Rezende Mahnke M, Tiburski Neto A. Antimicrobial susceptibility of Escherichia coli to extracts of plant species Zingiber officinale and Hedychium coronarium. Braz J Biol 85:e291313, 2025. e-Pub 2025. PMID: 41124386.
Althans, AR, Holder-Murray, J, Hopkins, K, Gamboa, AC, Regenbogen, SE, Silviera, ML, Hawkins, AT, Ejaz, A, Balch, GC, Tessler, RA. Role of Adjuvant Chemotherapy After Curative Resection in Stage II and III Rectal Cancer. Journal of Surgical Research 303:254-260, 2024. e-Pub 2024. PMID: 39383599.
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC Jr, Rivard S, Regenbogen S, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch GC, Wise PE. Short-Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium. J Surg Oncol, 2024. e-Pub 2024. PMID: 39400312.
Muldoon RL, Bethurum AJ, Gamboa AC, Zhang K, Ye F, Regenbogen SE, Abdel-Misih S, Ejaz A, Wise PE, Silviera M, Holder-Murray J, Balch GC, Hawkins AT. Comparison of outcomes of abdominoperineal resection vs low anterior resection in very-low rectal cancer. J Gastrointest Surg 28(9):1450-1455, 2024. e-Pub 2024. PMID: 38897287.
Mirza MB, Gamboa AC, Irlmeier R, Hopkins B, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Wise PE, Ye F, Idrees K, Hawkins AT, Balch GC, Khan A. Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer. J Surg Res 300:494-502, 2024. e-Pub 2024. PMID: 38875948.
Ali D, Syed M, Gamboa AC, Hawkins AT, Regenbogen SE, Holder-Murray J, Silviera M, Ejaz A, Balch GC, Khan A. Association of omental pedicled flap with anastomotic leak following low anterior resection for rectal cancer. J Surg Oncol 129(5):930-938, 2024. e-Pub 2024. PMID: 38167808.
Hrebinko K, Anto VP, Reitz KM, Gamboa AC, Regenbogen SE, Hawkins AT, Hopkins MB, Ejaz A, Bauer PS, Wise PE, Balch GC, Holder-Murray J. Prophylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal Cancer Consortium. Int J Colorectal Dis 39(1):39, 2024. e-Pub 2024. PMID: 38498217.
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC, Rivard S, Regenbogen S, Mohammed M, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch G, Silviera ML. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium. J Surg Oncol 129(2):254-263, 2024. e-Pub 2024. PMID: 37792637.
Varlamos CJ, Sinco B, Van Weiren I, Regenbogen S, Gamboa AC, Silviera M, Abdel-Misih SRZ, Hawkins AT, Balch G, Hendren S. Close distal margin is associated with locoregional rectal cancer recurrence: A multicenter study. J Surg Oncol 128(7):1106-1113, 2023. e-Pub 2023. PMID: 37458131.
Keilson JM, Gamboa AC, Turgeon MK, Maguire L, Hrebinko K, Holder-Murray J, Wiseman JT, Ejaz A, Hawkins AT, Otegbeye E, Silviera M, Maithel SK, Balch GC. Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?. Ann Surg Oncol 30(1):224-232, 2023. e-Pub 2023. PMID: 36269446.
Edwards GC, Gamboa AC, Feng MP, Muldoon RL, Hopkins MB, Abdel-Misih S, Balch GC, Holder-Murray J, Mohammed M, Regenbogen SE, Silviera ML, Hawkins AT. What's the magic number? Impact of time to initiation of treatment for rectal cancer. Surgery 171(5):1185-1192, 2022. e-Pub 2022. PMID: 34565608.
Bourne KM, Hall J, Stiles LE, Sheldon RS, Shibao CA, Okamoto LE, Garland EM, Gamboa AC, Peltier A, Diedrich A, Biaggioni I, Robertson D, Raj SR. Symptom Presentation and Access to Medical Care in Patients With Postural Orthostatic Tachycardia Syndrome: Role of Sex. CJC Open 3(12 Suppl):S44-S52, 2021. e-Pub 2021. PMID: 34993433.
Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, Grignol V, Bedi M, Mogal H, Clarke CN, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Pickens A, Cardona K. A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. J Surg Oncol 124(8):1477-1484, 2021. e-Pub 2021. PMID: 34374088.
Turgeon MK, Gamboa AC, Regenbogen SE, Holder-Murray J, Abdel-Misih SRZ, Hawkins AT, Silviera ML, Maithel SK, Balch GC. A US Rectal Cancer Consortium Study of Inferior Mesenteric Artery Versus Superior Rectal Artery Ligation: How High Do We Need to Go?. Dis Colon Rectum 64(10):1198-1211, 2021. e-Pub 2021. PMID: 34192711.
Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol 28(11):6882-6889, 2021. e-Pub 2021. PMID: 33740198.
Turgeon MK, Gamboa AC, Keilson JM, Maniko J, Maguire L, Hrebinko K, Holder-Murray J, Wiseman JT, Abdel-Misih S, Hamdan S, Hawkins AT, Bauer P, Silviera M, Maithel SK, Balch GC. Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium. J Surg Oncol 124(5):818-828, 2021. e-Pub 2021. PMID: 34270097.
Hanna DN, Gamboa AC, Balch GC, Regenbogen SE, Holder-Murray J, Abdel-Misih SRZ, Silviera ML, Feng MP, Stewart TG, Wang L, Hawkins AT. Perioperative Blood Transfusions Are Associated With Worse Overall Survival But Not Disease-Free Survival After Curative Rectal Cancer Resection: A Propensity Score-Matched Analysis. Dis Colon Rectum 64(8):946-954, 2021. e-Pub 2021. PMID: 34214054.
Lee RM, Gamboa AC, Turgeon MK, Prasad S, Kwakye G, Mohammed M, Holder-Murray J, Abdel-Misih S, Kimbrough C, Soda M, Hawkins AT, Chapman WC Jr, Silviera M, Maithel SK, Balch G. Revisiting the Value of Drains After Low Anterior Resection for Rectal Cancer: a Multi-institutional Analysis of 996 Patients. J Gastrointest Surg 25(8):2000-2010, 2021. e-Pub 2021. PMID: 32869144.
Gamboa AC, Lee RM, Turgeon MK, Varlamos C, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Feng MP, Hawkins AT, Bauer P, Silviera M, Maithel SK, Balch GC. Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium. Ann Surg Oncol 28(3):1712-1721, 2021. e-Pub 2021. PMID: 32968958.
Turgeon MK, Lee RM, Gamboa AC, Yopp A, Ryon EL, Goel N, Wang A, Lee AY, Luu S, Hsu C, Silberfein E, Maithel SK, Russell MC. Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study. HPB (Oxford) 23(3):422-433, 2021. e-Pub 2021. PMID: 32778389.
Eng NL, Mustin DE, Lovasik BP, Turgeon MK, Gamboa AC, Shah MM, Cardona K, Sarmiento JM, Russell MC, Maithel SK, Switchenko JM, Kooby DA. Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma. Ann Surg Oncol 28(2):1097-1105, 2021. e-Pub 2021. PMID: 32691338.
Turgeon MK, Gamboa AC, Rupji M, Lee RM, Switchenko JM, El-Rayes BF, Russell MC, Cardona K, Kooby DA, Staley CA, Maithel SK, Shah MM. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?. Ann Surg Oncol 28(1):97-105, 2021. e-Pub 2021. PMID: 32524459.
Lee RM, Gamboa AC, Turgeon MK, Zaidi MY, Kimbrough C, Leiting J, Grotz T, Lee AJ, Fournier K, Powers B, Dineen S, Baumgartner JM, Veerapong J, Mogal H, Clarke C, Wilson G, Patel S, Hendrix R, Lambert L, Pokrzywa C, Abbott DE, LaRocca CJ, Raoof M, Greer J, Johnston FM, Staley CA, Cloyd JM, Maithel SK, Russell MC. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC. J Surg Oncol 123(1):187-195, 2021. e-Pub 2021. PMID: 33002202.
Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol 27(13):4980-4995, 2020. e-Pub 2020. PMID: 32696303.
Gamboa AC, Ethun CG, Postlewait LM, Lopez-Aguiar AG, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Cardona K, Maithel SK. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target. Surg Oncol 35:460-465, 2020. e-Pub 2020. PMID: 33080545.
Turgeon MK, Gamboa AC, Lee RM, Zaidi MY, Kimbrough C, Grotz T, Fournier K, Powers B, Dineen S, Veerapong J, Clarke C, Mogal H, Patel SH, Lambert L, Ronnekleiv-Kelly S, Raoof M, Fackche N, Greer JB, Staley CA, Cloyd JM, Maithel SK, Winer JH. The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC. Ann Surg Oncol 27(13):4894-4907, 2020. e-Pub 2020. PMID: 32378087.
Lee RM, Gamboa AC, Turgeon MK, Yopp A, Ryon EL, Kronenfeld JP, Goel N, Wang A, Lee AY, Luu S, Hsu C, Silberfein E, Maithel SK, Russell MC. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative. Surg Oncol 35:120-125, 2020. e-Pub 2020. PMID: 32871546.
Muret-Wagstaff SL, Faber DA, Gamboa AC, Lovasik BP. Increasing the Effectiveness of "Stop the Bleed" Training Through Stepwise Mastery Learning with Deliberate Practice. J Surg Educ 77(5):1146-1153, 2020. e-Pub 2020. PMID: 32245715.
Lee RM, Liu Y, Gamboa AC, Staley CA, Kooby D, Russell MC, Cardona K, Maithel SK. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?. Surg Oncol 34:126-133, 2020. e-Pub 2020. PMID: 32891317.
Gamboa AC, Rupji M, Switchenko JM, Lee RM, Turgeon MK, Meyer BI, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Optimal timing and treatment strategy for pancreatic cancer. J Surg Oncol 122(3):457-468, 2020. e-Pub 2020. PMID: 32470166.
Gamboa AC, Meyer BI, Switchenko JM, Rupji M, Lee RM, Turgeon MK, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?. J Surg Oncol 122(3):412-421, 2020. e-Pub 2020. PMID: 32462769.
Gamboa AC, Zaidi MY, Lee RM, Sarmiento JM, Kooby DA, Russell MC, Cardona K, Maithel SK. The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz?. J Gastrointest Surg 24(9):2046-2053, 2020. e-Pub 2020. PMID: 31468334.
Lee RM, Gamboa AC, Turgeon MK, Yopp A, Ryon EL, Kronenfeld JP, Goel N, Wang A, Lee AY, Luu S, Hsu C, Silberfein E, Maithel SK, Russell MC. The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis. Am Surg 86(7):865-872, 2020. e-Pub 2020. PMID: 32721171.
Gamboa AC, Aveson VG, Zaidi MY, Lee RM, Jarnagin WR, Allen PJ, Drebin JA, Peter Kingham T, DeMatteo RP, Sarmiento JM, Russell MC, Cardona K, Kooby DA, D'Angelica MI, Maithel SK. Lending a hand for laparoscopic distal pancreatectomy: the optimal approach?. HPB (Oxford) 22(5):690-701, 2020. e-Pub 2020. PMID: 31601508.
Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. Clin Colorectal Cancer 19(1):e1-e7, 2020. e-Pub 2020. PMID: 31974019.
Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK. Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol 27(1):134-146, 2020. e-Pub 2020. PMID: 31243668.
Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol 27(1):156-164, 2020. e-Pub 2020. PMID: 31602579.
Gamboa AC, Liu Y, Lee RM, Zaidi MY, Staley CA, Kooby DA, Winer JH, Shah MM, Russell MC, Cardona K, Maithel SK. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?. J Surg Oncol 120(8):1293-1301, 2019. e-Pub 2019. PMID: 31621090.
Gamboa AC, Liu Y, Lee RM, Zaidi MY, Staley CA, Russell MC, Cardona K, Sullivan PS, Maithel SK. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique. J Surg Oncol 120(6):932-939, 2019. e-Pub 2019. PMID: 31448820.
DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?. J Surg Oncol 120(6):919-925, 2019. e-Pub 2019. PMID: 31385621.
Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona K. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?. J Am Coll Surg 229(5):449-457, 2019. e-Pub 2019. PMID: 31377411.
Lee RM, Liu Y, Gamboa AC, Zaidi MY, Kooby DA, Shah MM, Cardona K, Russell MC, Maithel SK. Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?. J Surg Oncol 120(4):611-623, 2019. e-Pub 2019. PMID: 31301148.
Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Ann Surg 270(3):422-433, 2019. e-Pub 2019. PMID: 31283562.
Gamboa AC, Rui L, Hongfang L, Wen A, Lu Q, Wang J, Katz MHG, Wang L, Lyu HG. Mapping multimorbidity trajectories for pancreas cancer for real world data.
Gamboa AC, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Tzeng CD, Katz MHG, Snyder RA. Characterizing the molecular profile and long-term outcomes of patients with young-onset pancreas adenocarcinoma.
Maher M, Duose DY, Chowdhuri SR, Coronel E, Gamboa AC, Tran Cao, HS, Javie M. Utilization of ERCP / pancreatic FNA supernatant for next-generation sequencing: a liquid biopsy approach to enhance detection and molecular characterization of cholangiocarcinoma.
White MG, Fallon EA, Helmink B, Chowdhury S, Fanaeian MM, Rivero-Hinojosa S, Bhutiani N, Aushev VN, Gamboa AC, Yousef MMG, Gu Y, Jurdi A, Liu MC, Scally C, Mansfield P, Raghav K, Kopetz S, Fournier K, Shen JP. The genomic landscape of appendiceal adenocarcinoma (AA) revealed by 855 Whole Exome Sequences (WES).
Gamboa AC, Pan C, Prakash LR, Ayabe RI, Ikoma N, Kim MP, Maxwell JE, Snyder RA, Tzeng CD, Katz MGH, Lyu HG. Evaluating synthetic data quality: Gaussian and CT-GAN models in replicating clinical outcomes in pancreas cancer research.

Review Articles

Gamboa AC, Snyder RA. Surgical Palliation for Pancreatic Cancer. Surg Oncol Clin N Am 35(1):167-179, 2026. e-Pub 2026. PMID: 41233069.
Gamboa AC, Kooby DA, Maithel SK, Gamblin TC. Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials. J Surg Oncol 129(1):63-70, 2024. e-Pub 2024. PMID: 38059310.
Gamboa AC, Maithel SK. Relevant Clinical Trials for GI Surgeons: a Review of Recent Findings. J Gastrointest Surg 24(10):2318-2335, 2020. e-Pub 2020. PMID: 32583326.
Gamboa AC, Maithel SK. The Landmark Series: Gallbladder Cancer. Ann Surg Oncol 27(8):2846-2858, 2020. e-Pub 2020. PMID: 32474816.
Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin 70(3):200-229, 2020. e-Pub 2020. PMID: 32275330.
Gamboa AC, Lowe M, Yushak ML, Delman KA. Surgical Considerations and Systemic Therapy of Melanoma. Surg Clin North Am 100(1):141-159, 2020. e-Pub 2020. PMID: 31753109.
Gamboa AC, Winer JH. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer. Cancers (Basel) 11(11), 2019. e-Pub 2019. PMID: 31717799.

Book Chapters

Gamboa AC, Cardona K. GIST. The SCORE Portal. http://www.surgicalcore.org.
Gamboa AC, Snyder, RA. Surgical Palliation for Pancreatic Cancer” In: Surgical Oncology Clinics – Pancreatic Cancer [In production]. In: Surgical Oncology Clinics – Pancreatic Cancer.
Gamboa AC, Maithel SK. Parenchymal Sparing Surgery – What’s Behind It?” In: Colorectal Cancer Liver Metastases: A Comprehensive Guide to Management [In press. In: Colorectal Cancer Liver Metastases: A Comprehensive Guide to Management.

Letters to the Editor

Hall J, Bourne KM, Stiles LE, Sheldon RS, Shibao CA, Okamoto LE, Garland EM, Gamboa AC, Diedrich A, Biaggioni I, Robertson D, Raj SR. Patients With Postural Orthostatic Tachycardia Syndrome Have Different Experiences in Health Care in Canada and the United States. Can J Cardiol 37: 1683-1684, 2021.

Less

CV information above last modified July 22, 2026

Adriana C. Gamboa, M.D., MSc

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Honors & Awards

Professional Memberships

Selected Presentations & Talks

National Presentations

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Other Articles

Book Chapters

Letters to the Editor

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Adriana C. Gamboa, M.D., MSc

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Honors & Awards

Professional Memberships

Selected Presentations & Talks

National Presentations

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Other Articles

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson